Literature DB >> 20414472

Wilcoxon-Mann-Whitney or t-test? On assumptions for hypothesis tests and multiple interpretations of decision rules.

Michael P Fay1, Michael A Proschan.   

Abstract

In a mathematical approach to hypothesis tests, we start with a clearly defined set of hypotheses and choose the test with the best properties for those hypotheses. In practice, we often start with less precise hypotheses. For example, often a researcher wants to know which of two groups generally has the larger responses, and either a t-test or a Wilcoxon-Mann-Whitney (WMW) test could be acceptable. Although both t-tests and WMW tests are usually associated with quite different hypotheses, the decision rule and p-value from either test could be associated with many different sets of assumptions, which we call perspectives. It is useful to have many of the different perspectives to which a decision rule may be applied collected in one place, since each perspective allows a different interpretation of the associated p-value. Here we collect many such perspectives for the two-sample t-test, the WMW test and other related tests. We discuss validity and consistency under each perspective and discuss recommendations between the tests in light of these many different perspectives. Finally, we briefly discuss a decision rule for testing genetic neutrality where knowledge of the many perspectives is vital to the proper interpretation of the decision rule.

Entities:  

Year:  2010        PMID: 20414472      PMCID: PMC2857732          DOI: 10.1214/09-SS051

Source DB:  PubMed          Journal:  Stat Surv


  10 in total

1.  Comparing several score tests for interval censored data.

Authors:  M P Fay
Journal:  Stat Med       Date:  1999-02-15       Impact factor: 2.373

2.  Cluster without fluster: The effect of correlated outcomes on inference in randomized clinical trials.

Authors:  Michael Proschan; Dean Follmann
Journal:  Stat Med       Date:  2008-03-15       Impact factor: 2.373

3.  A non-parametric test for interval-censored failure time data with application to AIDS studies.

Authors:  J Sun
Journal:  Stat Med       Date:  1996-07-15       Impact factor: 2.373

4.  Statistical method for testing the neutral mutation hypothesis by DNA polymorphism.

Authors:  F Tajima
Journal:  Genetics       Date:  1989-11       Impact factor: 4.562

5.  Preliminary report: Findings from the aspirin component of the ongoing Physicians' Health Study.

Authors: 
Journal:  N Engl J Med       Date:  1988-01-28       Impact factor: 91.245

6.  A proportional hazards model for interval-censored failure time data.

Authors:  D M Finkelstein
Journal:  Biometrics       Date:  1986-12       Impact factor: 2.571

7.  Properties of statistical tests of neutrality for DNA polymorphism data.

Authors:  K L Simonsen; G A Churchill; C F Aquadro
Journal:  Genetics       Date:  1995-09       Impact factor: 4.562

8.  Exact significance testing to establish treatment equivalence with ordered categorical data.

Authors:  C R Mehta; N R Patel; A A Tsiatis
Journal:  Biometrics       Date:  1984-09       Impact factor: 2.571

9.  Final report on the aspirin component of the ongoing Physicians' Health Study.

Authors: 
Journal:  N Engl J Med       Date:  1989-07-20       Impact factor: 91.245

10.  A randomized trial of aspirin and beta-carotene among U.S. physicians.

Authors:  C H Hennekens; K Eberlein
Journal:  Prev Med       Date:  1985-03       Impact factor: 4.018

  10 in total
  118 in total

Review 1.  Designing phenotyping studies for genetically engineered mice.

Authors:  C J Zeiss; J M Ward; H G Allore
Journal:  Vet Pathol       Date:  2011-09-19       Impact factor: 2.221

2.  A New Method for Diaphragmatic Maximum Relaxation Rate Ultrasonographic Measurement in the Assessment of Patients With Diaphragmatic Dysfunction.

Authors:  Christos P Loizou; Dimitrios Matamis; Giorgos Minas; Theodoros Kyprianou; Christakis D Loizou; Eleni Soilemezi; Entela Kotco; Constantinos S Pattichis
Journal:  IEEE J Transl Eng Health Med       Date:  2018-10-11       Impact factor: 3.316

3.  Models and simulation of 3D neuronal dendritic trees using Bayesian networks.

Authors:  Pedro L López-Cruz; Concha Bielza; Pedro Larrañaga; Ruth Benavides-Piccione; Javier DeFelipe
Journal:  Neuroinformatics       Date:  2011-12

4.  On the importance of statistics in breath analysis--hope or curse?

Authors:  Sandrah P Eckel; Jan Baumbach; Anne-Christin Hauschild
Journal:  J Breath Res       Date:  2014-02-24       Impact factor: 3.262

5.  NMR Metabolomics Protocols for Drug Discovery.

Authors:  Fatema Bhinderwala; Robert Powers
Journal:  Methods Mol Biol       Date:  2019

6.  An optimal Wilcoxon-Mann-Whitney test of mortality and a continuous outcome.

Authors:  Roland A Matsouaka; Aneesh B Singhal; Rebecca A Betensky
Journal:  Stat Methods Med Res       Date:  2016-12-29       Impact factor: 3.021

7.  GAREM1 regulates the PR interval on electrocardiograms.

Authors:  Hye Ok Kim; Ji Eun Lim; Myung Jun Kim; Ji-One Kang; Sung-Moon Kim; Jeong Min Nam; Jihoon Tak; Hiroaki Konishi; Tasuku Nishino; In Song Koh; Young-Ho Jin; Hyung Hwan Baik; Jin-Bae Kim; Mi Kyung Kim; Bo Youl Choi; Sang-Hak Lee; Yangsoo Jang; Jinho Shin; Bermseok Oh
Journal:  J Hum Genet       Date:  2017-12-22       Impact factor: 3.172

8.  Univariate description and bivariate statistical inference: the first step delving into data.

Authors:  Zhongheng Zhang
Journal:  Ann Transl Med       Date:  2016-03

9.  Metabolomics Analyses from Tissues in Parkinson's Disease.

Authors:  Fatema Bhinderwala; Shulei Lei; Jade Woods; Jordan Rose; Darrell D Marshall; Eli Riekeberg; Aline De Lima Leite; Martha Morton; Eric D Dodds; Rodrigo Franco; Robert Powers
Journal:  Methods Mol Biol       Date:  2019

10.  Metabolic disturbances identified by SPECT-CT in patients with a clinical diagnosis of sacroiliac joint incompetence.

Authors:  Mel Cusi; Jennifer Saunders; Hans Van der Wall; Ignac Fogelman
Journal:  Eur Spine J       Date:  2013-03-01       Impact factor: 3.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.